Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is providing ...
PCMag UK on MSN
Be Quiet Dark Mount
None ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results